These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11889687)

  • 21. Use of human immunodeficiency virus postexposure prophylaxis in adolescent sexual assault victims.
    Olshen E; Hsu K; Woods ER; Harper M; Harnisch B; Samples CL
    Arch Pediatr Adolesc Med; 2006 Jul; 160(7):674-80. PubMed ID: 16818831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
    Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
    Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UK Guideline for the use of post-exposure prophylaxis for HIV following sexual exposure.
    Fisher M; Benn P; Evans B; Pozniak A; Jones M; Maclean S; Davidson O; Summerside J; Hawkins D;
    Int J STD AIDS; 2006 Feb; 17(2):81-92. PubMed ID: 16464267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonoccupational postexposure prophylaxis following sexual assault in industrialized low-HIV-prevalence countries: a review.
    Draughon JE; Sheridan DJ
    Psychol Health Med; 2012; 17(2):235-54. PubMed ID: 22372741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical practice. Postexposure prophylaxis for HIV infection.
    Landovitz RJ; Currier JS
    N Engl J Med; 2009 Oct; 361(18):1768-75. PubMed ID: 19864675
    [No Abstract]   [Full Text] [Related]  

  • 26. The Danish PEP registry: experience with the use of postexposure prophylaxis (PEP) following sexual exposure to HIV from 1998 to 2006.
    Lunding S; Katzenstein TL; Kronborg G; Lindberg JA; Jensen J; Nielsen HI; Pedersen C; Jørgensen LB
    Sex Transm Dis; 2010 Jan; 37(1):49-52. PubMed ID: 19734819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CDC won't recommend non-occupational PET. Centers for Disease Control and Prevention.
    AIDS Alert; 1998 Feb; 13(2):17-8. PubMed ID: 11365035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seroconversion following nonoccupational postexposure prophylaxis against HIV.
    Roland ME; Neilands TB; Krone MR; Katz MH; Franses K; Grant RM; Busch MP; Hecht FM; Shacklett BL; Kahn JO; Bamberger JD; Coates TJ; Chesney MA; Martin JN
    Clin Infect Dis; 2005 Nov; 41(10):1507-13. PubMed ID: 16231265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New antiretroviral therapy guidelines.
    Vella S
    AIDS Clin Care; 1996 Oct; 8(10):79-81. PubMed ID: 11363985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New guidelines for antiretroviral therapy in nonoccupational postexposure prophylaxis.
    del Rio C
    AIDS Clin Care; 2005 Mar; 17(3):22. PubMed ID: 15828116
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV postexposure prophylaxis use among Ontario female adolescent sexual assault victims: a prospective analysis.
    Du Mont J; Myhr TL; Husson H; Macdonald S; Rachlis A; Loutfy MR
    Sex Transm Dis; 2008 Dec; 35(12):973-8. PubMed ID: 18836390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Testing and treatment after non-occupational exposures to STDs and HIV.
    Hardy EJ
    Med Health R I; 2012 Aug; 95(8):258-61. PubMed ID: 22970469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of HIV postexposure prophylaxis guidelines.
    Bartelli D; Moyer S; Mayer-Quezada D
    N J Med; 1998 Mar; 95(3):29-34. PubMed ID: 16013145
    [No Abstract]   [Full Text] [Related]  

  • 35. Surveillance of HIV exposure and postexposure prophylaxis among health care workers in Greece.
    Konte V; Nikolopoulos G; Raftopoulos V; Pylli M; Tsiara C; Makri E; Paraskeva D
    Public Health Nurs; 2007; 24(4):337-42. PubMed ID: 17553023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonoccupational postexposure HIV prevention: emergency physicians' current practices, attitudes, and beliefs.
    McCausland JB; Linden JA; Degutis LC; Ramanujam P; Sullivan LM; D'onofrio G
    Ann Emerg Med; 2003 Nov; 42(5):651-6. PubMed ID: 14581917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiretroviral therapy where resources are limited.
    Reynolds SJ; Bartlett JG; Quinn TC; Beyrer C; Bollinger RC
    N Engl J Med; 2003 May; 348(18):1806-9. PubMed ID: 12724489
    [No Abstract]   [Full Text] [Related]  

  • 38. HIV/AIDS: the management of treatment-experienced HIV-infected patients: new drugs and drug combinations.
    Wilson LE; Gallant JE
    Clin Infect Dis; 2009 Jan; 48(2):214-21. PubMed ID: 19072245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current practice of HIV postexposure prophylaxis treatment for sexual assault patients in an emergency department.
    Krause KH; Lewis-O'Connor A; Berger A; Votto T; Yawetz S; Pallin DJ; Baden LR
    Womens Health Issues; 2014; 24(4):e407-12. PubMed ID: 24981399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genotypic resistance tests for the management of postexposure prophylaxis.
    Puro V
    Scand J Infect Dis Suppl; 2003; 106():93-8. PubMed ID: 15000596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.